US Patent & Trademark Office
`
` US 8,865,921
` USPTO Transaction Information*
`
`SEQ.δ
`
`DATE
`
`DESCRIPTION
`
`1
`2
`3
`4
`5
`6
`7
`8
`9
`10
`11
`12
`13
`14
`15
`16
`17
`18
`19
`20
`21
`22
`23
`24
`25
`26
`27
`28
`29
`30
`31
`32
`
`Recordation of Patent Grant Mailed
`21 Oct 2014
`Issue Notification Mailed
`01 Oct 2014
`Patent Issue Date Used in PTA Calculation
`21 Oct 2014
`Dispatch to FDC
`19 Sep 2014
`Application Is Considered Ready for Issue
`19 Sep 2014
`Issue Fee Payment Verified
`18 Sep 2014
`Issue Fee Payment Received
`18 Sep 2014
`20 Jun 2014 Mail Notice of Allowance
`18 Jun 2014
`Document Verification
`18 Jun 2014
`Notice of Allowance Data Verification Completed
`17 Jun 2014
`Information Disclosure Statement considered
`17 Jun 2014
`Date Forwarded to Examiner
`13 Jun 2014
`Response after Final Action
`23 May 2014
`Electronic Information Disclosure Statement
`23 May 2014
`Information Disclosure Statement (IDS) Filed
`31 Mar 2014 Mail Final Rejection (PTOL - 326)
`25 Mar 2014
`Final Rejection
`13 Mar 2014
`Information Disclosure Statement considered
`13 Mar 2014
`Date Forwarded to Examiner
`07 Mar 2014
`Response after Non-Final Action
`10 Jan 2014
`Electronic Information Disclosure Statement
`10 Jan 2014
`Information Disclosure Statement (IDS) Filed
`11 Dec 2013 Mail Non-Final Rejection
`09 Dec 2013
`Non-Final Rejection
`22 Mar 2012
`Information Disclosure Statement considered
`20 Nov 2012
`Case Docketed to Examiner in GAU
`08 Nov 2012
`Transfer Inquiry to GAU
`25 Oct 2012
`PG-Pub Issue Notification
`22 Mar 2012
`Substitute Specification Filed
`22 Mar 2012
`Preliminary Amendment
`22 Mar 2012
`Request for Foreign Priority (Priority Papers May Be Included)
`22 Mar 2012
`Electronic Information Disclosure Statement
`
`*
`
`δ
`
` Document generated on 04/30/2015 by PATENTEC from official USPTO records, external to this file.
` Information deemed accurate, but not Certified.
` Transaction Sequence Number (SEQ.) is unrelated to Paper Number in File Table of contents.
`
` Page 1 of 2
`
`Quality Patent Documents
`
`TM
`
` 2001 Jefferson Davis Hwy, Arlington, VA 22202
` 1-703-418-2777 (cid:122) www.patentec.com (cid:122) info@ patentec.com
` © 2015 PATENTEC
`
`Petitioners' Exhibit 1011, Page 1 of 629
`
`

`
`US Patent & Trademark Office
`
`US 8,865,921
`USPTO Transaction Information*
`
`SEQ.δ
`33
`34
`35
`36
`37
`38
`
`39
`40
`41
`42
`43
`
`DATE
`13 Aug 2012
`09 Jul 2012
`18 Jul 2012
`18 Jul 2012
`18 Jul 2012
`09 Jul 2012
`
`DESCRIPTION
`Application Dispatched from OIPE
`371 Completion Date
`Sent to Classification Contractor
`Filing Receipt
`Notice of DO/EO Acceptance Mailed
`Additional Application Filing Fees
`A statement by one or more inventors satisfying the requirement under 35
`09 Jul 2012
`USC 115, Oath of the Applic
`17 May 2012 Notice of DO/EO Missing Requirements Mailed
`22 Mar 2012
`Information Disclosure Statement (IDS) Filed
`22 Mar 2012
`Cleared by OIPE CSR
`22 Mar 2012
`Initial Exam Team nn
`
`* Document generated on 04/30/2015 by PATENTEC from official USPTO records, external to this file.
`Information deemed accurate, but not Certified.
`δ Transaction Sequence Number (SEQ.) is unrelated to Paper Number in File Table of contents.
`
`Page 2 of 2
`
`Quality Patent Documents
`
`TM
`
`2001 Jefferson Davis Hwy, Arlington, VA 22202
`1-703-418-2777 (cid:122) www.patentec.com (cid:122) info@patentec.com
`© 2015 PATENTEC
`
`Petitioners' Exhibit 1011, Page 2 of 629
`
`

`
` Patent Assignment Abstract of Title
`
`
`Total Assignments: 1
`Issue Dt: 10/21/2014
`Patent #: 8865921
`Application #: 13497690 Filing Dt: 07/09/2012
`Intl Reg #:
`Publication #: US20120271060 Pub Dt: 25-OCT-12
`PCT #: NONE
`Inventors: Cesar Muñoz de Diego, Gerardus Johannes Maria Gruter, Matheus Adrianus Dam
`METHOD FOR THE PREPARATION OF 2,5-FURANDICARBOXYLIC ACID AND FOR THE
`PREPARATION OF THE DIALKYL ESTER OF 2,5-FURANDICARBOXYLIC ACID
`
`Title:
`
`
`
`Assignment: 1
`028514 /
`0284
`
`Reel/Frame:
`
`Received: 07/09/2012 Recorded: 07/09/2012 Mailed: 07/10/2012 Pages: 2
`
`
`Conveyance: ASSIGNMENT OF ASSIGNORS INTEREST (SEE DOCUMENT FOR DETAILS).
`
`Assignors: MUNOZ DE DIEGO, CESAR
`
`
`
`
`Exec Dt: 03/26/2012
`
`
`
`Exec Dt: 03/26/2012
`
`Exec Dt: 03/26/2012
`
`
`
`DAM, MATHEUS ADRIANUS
`
`
`
`GRUTER, GERARDUS JOHANNES MARIA
`
`
`
`Assignee: FURANIX TECHNOLOGIES B.V.
`29, ZEKERINGSTRAAT
`AMSTERDAM, NETHERLANDS 1014 BV
`
`
`Correspondent: HOFFMANN & BARON, LLP
`6900 JERICHO TURNPIKE
`SYOSSET, NY 11791
`
`
`
`
`
`
`
`Petitioners' Exhibit 1011, Page 3 of 629
`
`

`
` US Patent & Trademark Office
`
` US 8,865,921
` Maintenance Fee Statement*
`
`Fee Description
`
`Due at 3.5 years
`
`Due at 7.5 years
`
`Due at 11.5 years
`
`1
`
`2
`
`3
`
`Amount
`
`Surcharge
`
`Small
`Entity
`
`Attorney
`Docket No.
`
`0.00
`
`0.00
`
`0.00
`
`0.00
`
`0.00
`
`0.00
`
`Status
`
`NONE
`
`NONE
`
`NONE
`
`*
`
` Document generated on 04/30/2015 by PATENTEC from official USPTO records, external to this file.
` Information deemed accurate, but not Certified.
`
` Page 1 of 1
`
`Quality Patent Documents
`
`TM
`
` 2001 Jefferson Davis Hwy, Arlington, VA 22202
` 1-703-418-2777 (cid:122) www.patentec.com (cid:122) info@ patentec.com
` © 2015 PATENTEC
`
`Petitioners' Exhibit 1011, Page 4 of 629
`
`

`
`
`
`MISSING PAGE(S) FROM THE
`U.S. PATENT OFFICE
`OFFICIAL FILE WRAPPER
`
`
`File Wrapper Cover
`
`(Note: This page is not a part of the official USPTO record.)
`
`
`
`
`
`Petitioners' Exhibit 1011, Page 5 of 629
`
`

`
`PTO~139O (09-11)
`Approved for use through 4/30/2013. OMB 0651-0021
`U.S. Patent and Trademark Office; U.S. DEPARTMENT OF COMMERCE
`Under the Papewvork Reduction Act of 1995. no persons are required to respond to a collection of information unless it displays a valid OMB control number.
`
`TRANSMITTAL LETTER TO THE UNITED STATES
`é“3_:;?§gE7Y'l§?fi§/'f§g“”MBER
`DESIGNATEDIELECTED OFFICE (DOIEOIUS)
`u s APPLICATION NO (if known see 37 CFR1 5)
`CONCERNING A SUBMISSION UNDER 35 U.S.C. 371
`'
`'
`'
`’
`'
`INTERNATIoNAL APPLICATION NO.
`INTERNATIONAL FILING DATE
`PRIORITY DATE CLAIMED
`EMMMMRIIIIIEMMMIIIIInmmmg
`K./TE|TEHO(§|I')N\|:/l(E)NR-'Tlr‘-‘IE PREPARATION OF 2,5-FURANDICARBOXYLIC ACID AND FOR THE PREPARATION OF THE
`APPLlCANT(S) FOR D_o/Eo/us
`Cesar Munoz de Diego; Matheus Adrianus Darn; Gerardus Johanes Maria Gruter
`Applicant herewith submits to the United States Designated/Elected Office (DO/EO/US) the following items and other information:
`
`This is a FIRST submission of items concerning a submission under 35 U.S.C. 371.
`
`I: This is a SECOND or SUBSEQUENT submission of items concerning a submission under 35 U.S.C. 371.
`
`This is an express request to begin national examination procedures (35 U.S.C. 371(f)). The submission must include items
`(5), (6), (9) and (21) indicated below.
`
`I: The US has been elected (Article 31).
`
`A copy of the International Application as filed (35 U.S.C. 371(c)(2))
`
`a. CI is attached hereto (required only if not communicated by the International Bureau).
`
`b.
`
`has been communicated by the international Bureau.
`
`0. CI is not required, as the application was filed in the United States Receiving Office (RO/US).
`
`An English language translation of the International Application as filed (35 U.S.C. 371(c)(2)).
`
`a. D is attached hereto.
`
`b. El has been previously submitted under 35 U.S.C. 154(d)(4).
`
`Amendments to the claims of the International Application under PCT Article 19 (35 U.S.C. 371(c)(3))
`
`a. I: are attached hereto (required only if not communicated by the international Bureau).
`
`b. I: have been communicated by the International Bureau.
`
`c. I: have not been made; however, the time limit for making such amendments has NOT expired.
`
`d.
`
`have not been made and will not be made.
`
`An English language translation of the amendments to the claims under PCT Article 19 (35 U.S.C. 371(c)(3)).
`
`An oath or declaration of the inventor(s) (35 U.S.C. 371(c)(4)).
`
`An English language translation of the annexes of the international Preliminary Examination Report under PCT
`Article 36 (35 U.S.C. 371(c)(5)).
`
`Items 11 to 20 below concern document(s) or information included:
`\
`
`An Information Disclosure Statement under 37 CFR 1.97 and 1.98.
`
`DHDIIIIDI
`
`An assignment document for recording. A separate cover sheet in compliance with 37 CFR 3.28 and 3.31 is included.
`
`A preliminary amendment.
`
`An Application Data Sheet under 37 CFR 1.76.
`
`A substitute specification.
`
`A power of attorney and/or change of address letter.
`
`A computer-readable form of the sequence listing in accordance with PCT Rule 13ter.3 and 37 CFR 1821- 1.825.
`
`A second copy of the published International Application under 35 U.S.C. 154(d)(4).
`
`A second copy of the English language translation of the international application under 35 U.S.C. 154(d)(4).
`
`This collection of information is required by 37 CFR 1.414 and 1.491-1 .492. The information is required to obtain or retain a b enefit by the public, w hich is to file (and by the
`USPTO to pro cess) an application . Confidentiality is governed by 35 U.S.C. 122 and 37 CFR 1.11 and 1.14. This collection is estimated to take 15 minutes to complete.
`including gathering information, preparing, and submitting the completed form to the USPTO. Time will vary depending upon the individual case. Any comments on the amount
`of time you require to complete this form and/or suggestions for reducing this burden. should be sent to the Chief Information Officer. U.S. Patent and Trademark Office. U.S.
`Department of Commerce. P.O. Box 1450, Alexandria, VA 22313-1450. DO NOT SEND FEE 8 OR COMPLE TED FORMS TO THIS ADDRESS. SEND TO: Mail Stop PCT,
`Commissioner for Patents, P.O. Box 1450, Alexandria, VA 22313-1450.
`Page 1 of 3
`
`Petitioners‘ Exhibit 1011, Page 6 of 629
`
`Petitioners' Exhibit 1011, Page 6 of 629
`
`

`
`PTO-1390 (09-11)
`Approved for use through 4/30/2013. OMB 0651-0021
`U.S. Patent and Trademark Office; U.S. DEPARTMENT OF COMMERCE
`Under the Paperwork Reduction Act of 1995, no persons are required to respond to a collection of information unless it displays a valid OMB control number.
`u.s. APPLICATION NO. (if known, see 37 CFR 1.5)
`INTERNATIONAL APPLICATION No.
`ATTORNEY’S DOCKET NUMBER
`PCT/NL2010/050654
`903-457 PCT/US
`
`20.
`
`Other items or information:
`
`
`
`
`
`IDS Certification; General Authorization for Extension of Time; PCT International Search Report; NL Search Report;
`Copy of Priority Document; Statement for Submission of Priority Document; Statement for Submission of Substitute
`Specfications
`
`
`The following fees have been submitted
`
`
`
`21.
`
`Basic national fee (37 CFR 1.492(a)) ...................................................... .. $380
`
`22.
`Examination fee (37 CFR 1.492(0))
`
`
`
`
`
`
`
`
`CALCULATIONS
`
`PTO USE ONLY
`
`$ 380.00
`
`$250.00
`
`490_O0
`
`$
`
`H20-00
`
`
`
`If the written opinion prepared by ISA/US or the international preliminary examination report prepared
`by IPEA/US indicates all claims satisfy provisions of PCT Article 33(1)-(4) ........... .. $0
`All other situations .............................................................................................. ..$250
`
` 23.
`Search fee (37 CFR 1.492(0))
`
`If the written opinion of the ISA/US or the International preliminary examination report prepared by
`IPEAIUS indicates all claims satisfy provisions of PCT Article 33(1)—(4) ............... .. $0
`
`Search fee (37 CFR 1.445(a)(2)) has been paid on the international application to the USPTO as an
`International Searching Authority ................................................................. ..$120
`
`International Search Report prepared by an ISA other than the US and provided to the Office or
`
`previously communicated to the US by the IB .................................................. .. $490
`All other situations.............................................................................................. ..$620
`
`
`
`
`
`
`E Additional fee for specification and drawings filed in paper over 100 sheets (excluding sequence
`listing in compliance with 37 CFR 1.821(c) or (e) in an electronic medium or computer
`program listing in an electronic medium) (37 CFR 1.492(j)).
`The fee is $310 for each additional 50 sheets of paper or fraction thereof.
`
`
`
`Total Sheets
`
`Extra Sheets
`
`Number of each additional 50 or fraction
`thereof (round up to a whole number)
`
`RATE
`
`x$310
`
`Surcharge of $130.00 for furnishing any of the search fee, examination fee, or the oath or declaration
`after the date of commencement of the national stage (37 CFR 1.492(h)).
`CLAIMS
`NUMBER FILED
`NUMBER EXTRA
`
`RATE
`
`Towaims
`Independent claims
`
`15
`3
`
`-2°=mm-
`-3 =T X
`$250 Q
`
`TOTAL OF ABOVE CALCULATIONS =
`Applicant claims small entity status. See 37 CFR 1.27. Fees above are reduced by ‘/2.
`susmm =
`Processing fee of $130.00 for furnishing the English translation later than 30 months from the earliest
`claimed priority date (37 CFR 1.492(i)).
`1'
`TOTAL NATIONAL FEE =
`
`Fee for recording the enclosed assignment (37 CFR 1.21 (h)). The assignment must be accompanied
`by an appropriate cover sheet (37 CFR 3.28, 3.31). $40.00 per property
`+
`
`TOTAL FEES ENCLOSED =
`
`$1 ,120.00 _
`
`$ 560.00 _
`
`
` $ 560.00
`
`
`
`$ 560.00
`Amount to be
`refunded:
`Amount to be
`char ed
`
`$560.00
`
`
`
`
`
`
`Page 2 of 3
`
`Petitioners‘ Exhibit 1011, Page 7 of 629
`
`Petitioners' Exhibit 1011, Page 7 of 629
`
`

`
`PTO—139O (09-11)
`Approved for use through 4/30/2013. OMB 0651-0021
`U.S. Patent and Trademark Office; U.S. DEPARTMENT OF COMMERCE
`Under the Paperwork Reduction Act of 1995, no persons are required to respond to a collection of information unless it displays a valid OMB control number.
`
`_ El A check in the amount of $
`
`to cover the above fees is enclosed.
`
`.
`
`_
`
`Please charge my DepositAccount No. 082461
`
`in the amount of$ 560-00
`
`to cover the above fees.
`
`The Commissioner is hereby authorized to charge any additional fees which may be required, or credit any overpayment to Deposit
`Account No. ‘3'2461
`.
`
`. |:i
`
`Fees are to be charged to a credit card. WARNING: Information on this fon'n may become public. Credit card information should not
`be included on this form. Provide credit card information and authorization on PTO-2038. The PTO-2038 should only be mailed or faxed
`to the USPTO. However, when paying the basic national fee, the PTO-2038 may NOT be faxed to the USPTO.
`
`If filing by EFS—Web, do NOT attach the PTO-2038 form as a PDF along with your EFS-Web Submission. Please be
`ADVISORY:
`advised that this is not recommended and by doing so your credit card information may be displayed via PAIR. To protect your
`information, it is recommended paying fees online by using the electronic payment method.
`
`NOTE: Where an appropriate time limit under 37 CFR 1.495 has not been met, a petition to revive (37 CFR1.137(a) or (b)) must be filed
`and granted to restore the International Application to pending status.
`
`SEND ALL CORRESPONDENCE TO:
`Salvatore J. Abbruzzese, Esq.
`Hoffmann & Baron, LLP
`6900 Jericho Turnpike
`Syosset, New York 11791-4407
`
`Phone: 973-331-1700
`
`/John S. SOPKO! Reg_#41321/
`s.GNATURE
`John S_ Sopko
`NAME
`41321
`REGISTRATION NUMBER
`
`Page 3 of 3
`
`Petitioners‘ Exhibit 1011, Page 8 of 629
`
`Petitioners' Exhibit 1011, Page 8 of 629
`
`

`
`Privacy Act Statement
`
`The Privacy Act of 1974 (P.L. 93-579) requires that you be given certain information in connection
`with your submission of the attached form related to a patent application or patent. Accordingly,
`pursuant to the requirements of the Act, please be advised that: (1) the general authority for the
`collection of this information is 35 U.S.C. 2(b)(2); (2) furnishing of the information solicited is voluntary;
`and (3) the principal purpose for which the information is used by the U.S. Patent and Trademark
`Office is to process and/or examine your submission related to a patent application or patent. If you do
`not furnish the requested information, the U.S. Patent and Trademark Office may not be able to
`process and/or examine your submission, which may result in termination of proceedings or
`abandonment of the application or expiration of the patent.
`
`The information provided by you in this form will be subject to the following routine uses:
`
`‘I. The information on this form will be treated confidentially to the extent allowed under the
`Freedom of Information Act (5 U.S.C. 552) and the Privacy Act (5 U.S.C 552a). Records from
`this system of records may be disclosed to the Department of Justice to determine whether
`disclosure of these records is required by the Freedom of Information Act.
`A record from this system of records may be disclosed, as a routine use, in the course of
`presenting evidence to a court, magistrate, or administrative tribunal, including disclosures to
`opposing counsel in the course of settlement negotiations.
`A record in this system of records may be disclosed, as a routine use, to a Member of
`Congress submitting a request involving an individual, to whom the record pertains, when the
`individual has requested assistance from the Member with respect to the subject matter of the
`record.
`
`A record in this system of records may be disclosed, as a routine use, to a contractor of the
`Agency having need for the information in order to perform a contract. Recipients of
`information shall be required to comply with the requirements of the Privacy Act of 1974, as
`amended, pursuant to 5 U.S.C. 552a(m).
`A record related to an International Application filed under the Patent Cooperation Treaty in
`this system of records may be disclosed, as a routine use, to the International Bureau of the
`World Intellectual Property Organization, pursuant to the Patent Cooperation Treaty.
`A record in this system of records may be disclosed, as a routine use, to another federal
`agency for purposes of National Security review (35 U.S.C. 181) and for review pursuant to
`the Atomic Energy Act (42 U.S.C. 218(c)).
`A record from this system of records may be disclosed, as a routine use, to the Administrator,
`General Services, or his/her designee, during an inspection of records conducted by GSA as
`part of that agency’s responsibility to recommend improvements in records management
`practices and programs, under authority of 44 U.S.C. 2904 and 2906. Such disclosure shall
`be made in accordance with the GSA regulations governing inspection of records for this
`purpose, and any other relevant (i.e., GSA or Commerce) directive. Such disclosure shall not
`be used to make determinations about individuals.
`
`A record from this system of records may be disclosed, as a routine use, to the public after
`either publication of the application pursuant to 35 U.S.C. 122(b) or issuance of a patent
`pursuant to 35 U.S.C. 151. Further, a record may be disclosed, subject to the limitations of 37
`CFR 1.14, as a routine use, to the public if the record was filed in an application which
`became abandoned or in which the proceedings were terminated and which application is
`referenced by either a published application, an application open to public inspection or an
`issued patent.
`A record from this system of records may be disclosed, as a routine use, to a Federal, State,
`or local law enforcement agency, if the USPTO becomes aware of a violation or potential
`violation of law or regulation.
`
`Petitioners‘ Exhibit 1011, Page 9 of 629
`
`Petitioners' Exhibit 1011, Page 9 of 629
`
`

`
`PTOISBI14 (11-08)
`Approved for use through 09/30/2010. OMB 0651-0032
`U_S_ Patent and Trademark Office; U_S. DEPARTMENT OF COMMERCE
`Under the Paperwork Reduction Act of 1995, no persons are required to respond to a collection of information unless it contains a valid OMB control number.
`
`—
`—
`Application Data Sheet 37 CFR 1.76
`
`Attorney Docket Number
`_
`_
`Attttttcattott Number —
`
`document may be printed and included in a paper filed application.
`
`Title of invention
`
`METHOD FOR THE PREPARATION OF 2,5-FURANDICARBOXYLIC ACID AND FOR THE PREPARATION
`OF THE DIALKYL ESTER OF 2,5-FURANDICARBOXYLIC ACID
`
`The application data sheet is part of the provisional or nonprovisional application for which it is being submitted. The following form contains the
`bibliographic data arranged in a format specified by the United States Patent and Trademark Office as outlined in 37 CFR 1.76.
`This document may be completed electronically and submitted to the Office in electronic format using the Electronic Filing System (EFS) or the
`
`Secrecy Order 37 CFR 5.2
`
`E] Portions or all of the application associated with this Application Data Sheet may fall under a Secrecy Order pursuant to
`37 CFR 5.2 (Paper filers only. Applications that fall under Secrecy Order may not be filed electronically.)
`
`A licant Information:
`
`
`
`
`
`A |icant1
`
`
`
`C)Party of Interest under 35 U.S.C. 118
`Applicant Authority @|nventor OLegal Representative under 35 U.S.C. 117
`Prefix Middle Name
`Family Name
`Suffix
`
`
`Mufioz de Diego
`Residence Information (Select One) 0 US Residency @ Non US Residency 0 Active US Military Service
`
`
`
`
`
`Citizenship under 37 CFR1.41(b)i
`
`Mailing Address of Applicant:
`
`Address 1
`
`Address 2
`
`City
`
`do Furanix Technologies B.V.
`
`29, Zekeringstraat
`
`Postal Code
`
`1014 BV
`
`State! Province
`
`A licant 2
`
`
`
`Applicant Authority @|nventor OLegal Representative under 35 U.S.C. 117
`Family Name
`Prefix Given Name
`Middle Name
`
`Matheus
`Adrianus
`Dam
`
`Residence Information (Select One) 0 US Residency @ Non US Residency 0 Active US Military Service
`
`
`
`Citizenship under 37 CFR1.41(b)i
`
`Mailing Address of Applicant:
`
`Address 1
`
`Address 2
`
`City
`
`do Furanix Technologies B.V.
`
`29, Zekeringstraat
`
`Postal Code
`
`1014 BV
`
`State! Province
`
`A licant 3
`
`
`
`Applicant Authority @|nventor OLegal Representative under 35 U.S.C. 117
`Prefix Given Name
`Middle Name
`Family Name
`Suffix
`
`Johannes Maria
`Gruter
`Gerardus
`
`Residence Information (Select One) 0 US Residency @ Non US Residency 0 Active US Military Service
`
`°“V A'"S“*’”a’"
`
`EFS Web 2.2.2
`
`°°“""V °fRP r§LExhibit 1011, Page 10 of 629
`
`Petitioners' Exhibit 1011, Page 10 of 629
`
`

`
`PTOISBI14 (11-08)
`Approved for use through 09/30/2010. OMB 0651-0032
`U.S. Patent and Trademark Office; U.S. DEPARTMENT OF COMMERCE
`Under the Paperwork Reduction Act of 1995, no persons are required to respond to a collection of information unless it contains a valid OMB control number.
`
`.
`
`.
`
`Application Data Sheet 37 CFR 1.76—Application Number
`
`903457 PCT/Us
`
`Title of Invention
`
`METHOD FOR THE PREPARATION OF 2,5-FURANDICARBOXYLIC ACID AND FOR THE PREPARATION
`OF THE DIALKYL ESTER OF 2,5-FURANDICARBOXYLIC ACID
`
`Citizenship under 37 CFR 1.41(b) I
`
`NL
`
`Mailing Address of Applicant:
`
`Address 1
`c/o Furanix Technologies B.V.
`
`29, Zekeringstraat
`Address 2
`5*a*e’P'°V‘"°°
`NL
`Information blocks may be
`
`
`
`Add
`
`
`
`1014 BV
`Postal code
`Inventor
`All
`Inventors Must Be Listed - Additional
`generated within this form by selecting the Add button.
`
`Correspondence Information:
`
`Enter either Customer Number or complete the Correspondence Information section below.
`For further information see 37 CFR 1.33(a).
`
`|:| An Address is being provided for the correspondence Information of this application.
`
`Customer Number
`
`23869
`
`Email Address
`
`JSOPKO@HB|PLAW.COM
`
`Application Information:
`
`Title of the Invention
`
`Attorney Docket Number
`
`Application Type
`
`METHOD FOR THE PREPARATION OF 2,5-FURANDICARBOXYLIC ACID AND FOR THE
`PREPARATION OF THE DIALKYL ESTER OF 2,5-FURANDICARBOXYLIC ACID
`903-457 PCTIUS
`I Small Entity Status Claimed
`Nonprovisional
`
`
`
`Utility
`
`Subject Matter
`
`Suggested Class (if any)
`Sub Class (if any)
`
`Suggested Technology Center (if any)
`
`Total Number of Drawing Sheets (if any) - Suggested Figure for Publication (if any)
`Publication Information:
`
`
`
`
`
`|:| Request Early Publication (Fee required at time of Request 37 CFR 1.219)
`
`Request NOt t0 Publish. I hereby request that the attached application not be published under 35 U.S.
`E] C. 122(b) and certify that the invention disclosed in the attached application has not and will not be the subject of
`an application filed in another country, or under a multilateral international agreement, that requires publication at
`eighteen months after filing.
`
`Representative Information:
`
`Representative information should be provided for all practitioners having a power of attorney in the application. Providing
`this information in the Application Data Sheet does not constitute a power of attorney in the application (see 37 CFR 1.32).
`Enter
`either Customer Number
`or
`complete
`the Representative Name
`section
`below.
`If
`both
`are completed the Customer Number will be used for the Representative Information during processing.
`
`sections
`
`Please Select One:
`
`| © Customer Number Q Q0HiTiteP§§§qtWné}7@§11.9)
`
`EFS Web 2.2.2
`
`Petitioners' Exhibit 1011, Page 11 of 629
`
`

`
`PTOISBI14 (11-08)
`Approved for use through 09/30/2010. OMB 0651-0032
`U_S_ Patent and Trademark Office; U_S. DEPARTMENT OF COMMERCE
`Under the Paperwork Reduction Act of 1995, no persons are required to respond to a collection of information unless it contains a valid OMB control number.
`
`.
`
`Appllcatlon Data Sheet 37 CFR 1.76 APP'0=a0°" Number —
`
`.
`
`Title of Invention
`
`METHOD FOR THE PREPARATION OF 2,5-FURANDICARBOXYLIC ACID AND FOR THE PREPARATION
`OF THE DIALKYL ESTER OF 2,5-FURANDICARBOXYLIC ACID
`
`Customer Number
`
`23869
`
`Domestic BenefitINational Stage Information:
`
`This section allows for the applicant to either claim benefit under 35 U.S.C. 119(e), 120, 121, or 365(0) or indicate National Stage
`entry from a PCT application. Providing this information in the application data sheet constitutes the specific reference required by
`35 U.S.C. 119(e) or 120, and 37 CFR 1.78(a)(2) or CFR 1.‘/8(a)(4), and need not otherwise be made part of the specification.
`
`Prior Application Status
`Application Number
`
`Prior Application Status
`Application Number
`PCT/NL2010/050654
`Additional Domestic Benefit/National Stage Data may be generated within this form
`by selecting the Add button.
`
`Filing Date (YYYY-MM-DD)
`2010-1000
`
`Filing Date (YYYY-MM-DD)
`2009-10-07
`Add
`
`Foreign Priority Information:
`
`This section allows for the applicant to claim benefit of foreign priority and to identify any prior foreign application for which priority is
`not claimed. Providing this information in the application data sheet constitutes the claim for priority as required by 35 U.S.C. 119(b)
`and 37 CFR 1_55(a)_
`
`Parent Filing Date (YYYY-MM-DD)
`Application Number
`0000-10-07
`0000000
`Additional Foreign Priority Data may be generated within this form by selecting the
`Add button.
`
`
`
`-
`Priority Claimed
`63 Yes 0 0'0
`Add
`
`Assignee Information:
`Providing this information in the application data sheet does not substitute for compliance with any requirement of part 3 of Title 37
`of the CFR to have an assignment recorded in the Office.
`
`Assi nee 1
`
`
`If the Assignee is an Organization check here.
`
`Organization Name
`
`Furanix Technologies B_V_
`
`Mailing Address Information:
`
`Address 1
`
`Address 2
`
`29, Zekeringstraat
`
`0000000000 —
`Email Address
`
`Additional Assignee Data may be generated within this form by selecting the Add
`
`-_.“_ I A“. Q D I
`EFS Web 2.2.2
`
`
`
`
`
`Petitioners' Exhibit 1011, Page 12 of 629
`
`

`
`PTOISBI14 (11-OB)
`Approved for use through 09/30/2010. OMB 0651-0032
`U.S. Patent and Trademark Office; U.S. DEPARTMENT OF COMMERCE
`Under the Paperwork Reduction Act of 1995, no persons are required to respond to a collection of information unless it contains a valid OMB control number.
`
`.
`
`Application Data Sheet 37 CFR 1.76 APP'i==a“°" Number —
`
`.
`
`We °f I”Ve”tI°”
`
`METHOD FOR THE PREPARATION OF 2,5-FURANDICARBOXYLIC ACID AND FOR THE PREPARATION
`OF THE DIALKYL ESTER OF 2,5—FURAND|CARBOXYL|C ACID
`
`Signature:
`
`A signature of the applicant or representative is required in accordance with 37 CFR 1.33 and 10.18. Please see 37
`CFR 1.4(d) for the form of the signature.
`
`
`
`/John S. SOPKO, Reg. # 41321! Date (YYYY-MM-DD)Signature 2012-03-22
`
`
`
`
`
`First Name
`
`John
`
`Last Name
`
`Sopko
`
`Registration Number
`
`41321
`
`This collection of information is required by 37 CFR 1.76. The information is required to obtain or retain a benefit by the public which
`is to file (and by the USPTO to process) an application. Confidentiality is governed by 35 U.S.C. 122 and 37' CFR 1.14. This
`collection is estimated to take 23 minutes to complete, including gathering, preparing, and submitting the completed application data
`sheet form to the USPTO. Time will vary depending upon the individual case. Any comments on the amount of time you require to
`complete this form and/or suggestions for reducing this burden, should be sent to the Chief Information Officer, U.S. Patent and
`Trademark Office, U.S. Department of Commerce, P.O. Box 1450, Alexandria, VA 22313-1450. DO NOT SEND FEES OR
`COMPLETED FORMS TO THIS ADDRESS. SEND TO: Commissioner for Patents, P.0. Box 1450, Alexandria, VA 22313-1450.
`
`EFS Web 2.2.2
`
`Petitioners‘ Exhibit 1011, Page 13 of 629
`
`Petitioners' Exhibit 1011, Page 13 of 629
`
`

`
`Privacy Act Statement
`
`The Privacy Act of 1974 (P.L. 93-579) requires that you be given certain information in connection with your submission of the attached form related to
`a patent application or patent. Accordingly, pursuant to the requirements of the Act, please be advised that:
`(1) the general authority for the collection
`of this information is 35 U.S.C. 2(b)(2); (2) furnishing of the information solicited is voluntary; and (3) the principal purpose for which the information is
`used by the U.S. Patent and Trademark Office is to process and/or examine your submission related to a patent application or patent.
`If you do not
`furnish the requested information, the U.S. Patent and Trademark Office may not be able to process and/or examine your submission, which may
`result in termination of proceedings or abandonment of the application or expiration of the patent.
`
`The information provided by you in this form will be subject to the following routine uses:
`
`1.
`
`The information on this form will be treated confidentially to the extent allowed under the Freedom of Information Act (5 U.S.C. 552)
`and the Privacy Act (5 U.S.C. 552a). Records from this system of records may be disclosed to the Department of Justice to determine
`whether the Freedom of Information Act requires disclosure of these records.
`
`A record from this system of records may be disclosed, as a routine use, in the course of presenting evidence to a court, magistrate, or
`administrative tribunal, including disclosures to opposing counsel in the course of settlement negotiations.
`
`A record in this system of records may be disclosed, as a routine use, to a Member of Congress submitting a request involving an
`individual, to whom the record pertains, when the individual has requested assistance from the Member with respect to the subject matter of
`the record.
`
`A record in this system of records may be disclosed, as a routine use, to a contractor of the Agency having need for the information in
`order to perform a contract. Recipients of information shall be required to comply with the requirements of the Privacy Act of 1974, as
`amended, pursuant to 5 U.S.C. 552a(m)_
`
`A record related to an International Application filed under the Patent Cooperation Treaty in this system of records may be disclosed,
`as a routine use, to the International Bureau of the World Intellectual Property Organization, pursuant to the Patent Cooperation Treaty.
`
`A record in this system of records may be disclosed, as a routine use, to another federal agency for purposes of National Security
`review (35 U.S.C. 181) and for review pursuant to the Atomic Energy Act (42 U.S.C. 218(c))_
`
`A record from this system of records may be disclosed, as a routine use, to the Administrator, General Services, or his/her designee,
`during an inspection of records conducted by GSA as part of that agency's responsibility to recommend improvements in records
`management practices and programs, under authority of 44 U.S.C. 2904 and 2906. Such disclosure shall be made in accordance with the
`GSA regulations governing inspection of records for this purpose, and any other relevant (i.e., GSA or Commerce) directive. Such
`disclosure shall not be used to make determinations about individuals.
`
`A record from this system of records may be disclosed, as a routine use, to the public after either publication of the application pursuant
`to 35 U.S.C. 122(b) or issuance ofa patent pursuant to 35 U.S.C. 151. Further, a record may be disclosed, subject to the limitations of37
`CFR 1.14, as a routine use, to the public if the record was filed in an application which became abandoned or in which the proceedings were
`terminated and which application is referenced by either a published application, an application open to public inspections or an issued
`patent.
`
`A record from this system of records may be disclosed, as a routine use, to a Federal, State, or local law enforcement agency, if the
`USPTO becomes aware of a violation or potential violation of law or regulation.
`
`EFS Web 2.2.2
`
`Petitioners‘ Exhibit 1011, Page 14 of 629
`
`Petitioners' Exhibit 1011, Page 14 of 629
`
`

`
`IN THE UNITED STATES PATENT AND TRADEMARK OFFICE
`
`PATENT
`
`Applicants:
`
`Cesar Munoz de Diego et al.
`
`Examin